| Literature DB >> 22126797 |
Keiji Mochida1, Ayumi Hasegawa, Kyuichi Taguma, Atsushi Yoshiki, Atsuo Ogura.
Abstract
Cryopreservation of mouse embryos is a technological basis that supports biomedical sciences, because many strains of mice have been produced by genetic modifications and the number is consistently increasing year by year. Its technical development started with slow freezing methods in the 1970s(1), then followed by vitrification methods developed in the late 1980s(2). Generally, the latter technique is advantageous in its quickness, simplicity, and high survivability of recovered embryos. However, the cryoprotectants contained are highly toxic and may affect subsequent embryo development. Therefore, the technique was not applicable to certain strains of mice, even when the solutions are cooled to 4°C to mitigate the toxic effect during embryo handling. At the RIKEN BioResource Center, more than 5000 mouse strains with different genetic backgrounds and phenotypes are maintained(3), and therefore we have optimized a vitrification technique with which we can cryopreserve embryos from many different strains of mice, with the benefits of high embryo survival after vitrifying and thawing (or liquefying, more precisely) at the ambient temperature(4). Here, we present a vitrification method for mouse embryos that has been successfully used at our center. The cryopreservation solution contains ethylene glycol instead of DMSO to minimize the toxicity to embryos(5). It also contains Ficoll and sucrose for prevention of devitrification and osmotic adjustment, respectively. Embryos can be handled at room temperature and transferred into liquid nitrogen within 5 min. Because the original method was optimized for plastic straws as containers, we have slightly modified the protocol for cryotubes, which are more easily accessible in laboratories and more resistant to physical damages. We also describe the procedure of thawing vitrified embryos in detail because it is a critical step for efficient recovery of live mice. These methodologies would be helpful to researchers and technicians who need preservation of mouse strains for later use in a safe and cost-effective manner.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22126797 PMCID: PMC3308583 DOI: 10.3791/3155
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355
| NaCl | 58.4 | 136.98 | 800.0 |
| KCl | 74.6 | 2.68 | 20.0 |
| KH2PO4 | 136.1 | 1.47 | 20.0 |
| Na2HPO4.12H2O | 358.14 | 8.04 | 288.1 |
| MgCl2,6H2O | 203.3 | 0.49 | 10.0 |
| Glucose | 180.2 | 5.56 | 100.0 |
| Na pyruvate | 110 | 0.33 | 3.6 |
| CaCl2,2H2O | 147 | 0.9 | 13.2 |
| Penicillin G | 6.0 (approx) |
| Ficoll 70 | 6.0 g |
| Sucrose | 3.424 g |
| BSA | 42.0 mg |
| Ethylene glycol | 1 ml | 2 ml |
| FS solution | 4 ml | 3 ml |
| Strain | Total No. of tubes | No. of embryos vitrified | Recovered (No. (%)) | Morphologically normal (No. (%)) | Development to blastocysts (No. (%)) |
| C57BL/6J | 20 | 400 | 397 (99) | 394 (99) | 342 (87) |
| BALB/cA | 15 | 300 | 296 (99) | 282 (95) | 238 (84) |
| ICR | 24 | 480 | 474 (99) | 443 (93) | 398 (90) |
| Condition of embryos | No. of recipient females | No. of embryos transferred | Implantation sites (No. (%)) | Live offspring (No. (%)) |
| Fresh | 12 | 180 | 141 (78.3) | 110 (61.1) |
| Vitrified | 16 | 242 | 202 (83.5) | 125 (51.7) |